Sosmitha Girisa
Sosmitha Girisa
Research Scholar
Verified email at
Cited by
Cited by
FBXW7 in cancer: what has been unraveled thus far?
BL Sailo, K Banik, S Girisa, D Bordoloi, L Fan, CE Halim, H Wang, ...
Cancers 11 (2), 246, 2019
Potential of zerumbone as an anti-cancer agent
S Girisa, B Shabnam, J Monisha, L Fan, CE Halim, F Arfuso, KS Ahn, ...
Molecules 24 (4), 734, 2019
Piceatannol: A natural stilbene for the prevention and treatment of cancer
K Banik, AM Ranaware, C Harsha, T Nitesh, S Girisa, V Deshpande, ...
Pharmacological research 153, 104635, 2020
Targeting AKT/mTOR in oral cancer: Mechanisms and advances in clinical trials
C Harsha, K Banik, HL Ang, S Girisa, R Vikkurthi, D Parama, V Rana, ...
International journal of molecular sciences 21 (9), 3285, 2020
Inflammation, NF-κB, and chronic diseases: how are they linked?
AB Kunnumakkara, B Shabnam, S Girisa, C Harsha, K Banik, TB Devi, ...
Critical Reviews™ in Immunology 40 (1), 2020
Sorcin a potential molecular target for cancer therapy
B Shabnam, G Padmavathi, K Banik, S Girisa, J Monisha, G Sethi, L Fan, ...
Translational oncology 11 (6), 1379-1389, 2018
Potential application of zerumbone in the prevention and therapy of chronic human diseases
YP Singh, S Girisa, K Banik, S Ghosh, P Swathi, M Deka, G Padmavathi, ...
Journal of Functional Foods 53, 248-258, 2019
The vital role of ATP citrate lyase in chronic diseases
AD Khwairakpam, K Banik, S Girisa, B Shabnam, M Shakibaei, L Fan, ...
Journal of Molecular Medicine 98 (1), 71-95, 2020
COVID-19, cytokines, inflammation, and spices: How are they related?
AB Kunnumakkara, V Rana, D Parama, K Banik, S Girisa, H Sahu, ...
Life sciences, 119201, 2021
Rationalizing the therapeutic potential of apigenin against cancer
SA Ahmed, D Parama, E Daimari, S Girisa, K Banik, C Harsha, U Dutta, ...
Life Sciences, 118814, 2020
Upside and downside of tumor necrosis factor blockers for treatment of immune/inflammatory diseases
AB Kunnumakkara, KK Thakur, V Rana, B Bora, K Banik, E Khatoon, ...
Critical Reviews™ in Immunology 39 (6), 2019
Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer
S Girisa, D Parama, C Harsha, K Banik, AB Kunnumakkara
Exploration of Targeted Anti-tumor Therapy 1 (5), 313-342, 2020
Inflection of Akt/mTOR/STAT-3 cascade in TNF-α induced protein 8 mediated human lung carcinogenesis
D Bordoloi, K Banik, R Vikkurthi, KK Thakur, G Padmavathi, BL Sailo, ...
Life Sciences 262, 118475, 2020
From Simple Mouth Cavities to Complex Oral Mucosal Disorders—Curcuminoids as a Promising Therapeutic Approach
S Girisa, A Kumar, V Rana, D Parama, UD Daimary, S Warnakulasuriya, ...
ACS pharmacology & translational science 4 (2), 647-665, 2021
Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
S Girisa, S Henamayee, D Parama, V Rana, U Dutta, AB Kunnumakkara
Molecular Biomedicine 2 (1), 1-23, 2021
Lessons to Be Learnt from Ayurveda: Nutraceuticals and Cosmeceuticals from Ayurveda Herbs
P Garodia, S Girisa, V Rana, AB Kunnumakkara, BB Aggarwal
Ayurveda in the New Millennium, 199-222, 2020
Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review
E Verma, A Kumar, UD Daimary, D Parama, S Girisa, G Sethi, ...
Journal of Functional Foods 86, 104660, 2021
Current clinical developments in curcumin‐based therapeutics for cancer and chronic diseases
A Kumar, C Harsha, D Parama, S Girisa, UD Daimary, X Mao, ...
Phytotherapy Research, 2021
Antioxidant, anti-tyrosinase and anti-inflammatory activities of 3, 5-dihydroxy-4′, 7-dimethoxyflavone isolated from the leaves of Alpinia nigra
MK Gupta, S Senthilkumar, AK Chiranjivi, K Banik, S Girisa, ...
Phytomedicine Plus 1 (3), 100097, 2021
Xanthohumol from Hop: Hope for cancer prevention and treatment
S Girisa, Q Saikia, D Bordoloi, K Banik, J Monisha, UD Daimary, E Verma, ...
IUBMB life 73 (8), 1016-1044, 2021
The system can't perform the operation now. Try again later.
Articles 1–20